title: Glycolic acid peels versus salicylic-mandelic acid peels in active acne vulgaris and post-acne scarring and hyperpigmentation: a comparative study.
abstract: BACKGROUND
  Many clinicians have used glycolic acid (GA) peels for facial acne, scarring, and hyperpigmentation, mainly in lighter skin types. Salicylic-mandelic acid combination peels (SMPs) are a newer modality, and there have been no well-controlled studies comparing them with other conventional agents.
  
  
  OBJECTIVE
  To compare the therapeutic efficacy and tolerability of 35% GA peels and 20% salicylic-10% mandelic acid peels in active acne and post-acne scarring and hyperpigmentation.
  
  
  METHODS
  Forty-four patients with facial acne and post-acne scarring and hyperpigmentation were divided into two groups, with one receiving GA peels and the other SMPs at fortnightly intervals for six sessions. The treating physician performed objective evaluation of treatment outcomes. The patients, the treating physician, and an independent observer made subjective assessments. Side effects of both agents were also noted.
  
  
  RESULTS
  Both the agents were effective, but SMPs had a higher efficacy for most active acne lesions (p<.001) and hyperpigmentation (p<.001). Side effects were also lesser with SMPs.
  
  
  CONCLUSIONS
  Both the agents were effective and safe in Indian patients, with SMPs being better for active acne and post-acne hyperpigmentation.
authors.affiliation: Department of Dermatology, Venereology and Leprology, Maulana Azad Medical College and Associated Lok Nayak Hospital, New Delhi, India. vijaykga@gmail.com
authors.forename: Vijay Kumar
authors.initials: VK
authors.lastname: Garg
authors.forename: Surabhi
authors.initials: S
authors.lastname: Sinha
authors.forename: Rashmi
authors.initials: R
authors.lastname: Sarkar
mesh_terms: D000152:Acne Vulgaris / Q000150:complications / Q000628:therapy*; D000293:Adolescent; D000328:Adult; D002615:Chemexfoliation; D002921:Cicatrix / Q000209:etiology / Q000628:therapy*; D004338:Drug Combinations; D005260:Female; D006016:Glycolates / Q000009:adverse effects / Q000627:therapeutic use*; D006801:Humans; D017495:Hyperpigmentation / Q000628:therapy*; D008297:Male; D008333:Mandelic Acids / Q000008:administration & dosage* / Q000009:adverse effects; D020156:Salicylic Acid / Q000008:administration & dosage* / Q000009:adverse effects; D055815:Young Adult
chemical_list: D004338:Drug Combinations; D006016:Glycolates; D008333:Mandelic Acids; C031149:glycolic acid; C037938:mandelic acid; D020156:Salicylic Acid